Found: 12
Select item for more details and to access through your institution.
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- Vascular Health & Risk Management, 2015, v. 11, p. 165, doi. 10.2147/VHRM.S70907
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDLcholesterol, and non-HDLcholesterol in patients with dyslipidemia.
- Published in:
- Vascular Health & Risk Management, 2014, v. 10, p. 279, doi. 10.2147/VHRM.S58694
- By:
- Publication type:
- Article
Ezetimibe coadministered with fenofibrate: some safety questions: reply.
- Published in:
- European Heart Journal, 2005, v. 26, n. 21, p. 2344, doi. 10.1093/eurheartj/ehi466
- By:
- Publication type:
- Article
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia.
- Published in:
- European Heart Journal, 2005, v. 26, n. 9, p. 897, doi. 10.1093/eurheartj/ehi231
- By:
- Publication type:
- Article
High-Dose Statins in Acute Coronary Syndromes.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).
- Published in:
- 2004
- By:
- Publication type:
- journal article
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 1, p. 18, doi. 10.1002/clc.4960260105
- By:
- Publication type:
- Article
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
- Published in:
- Lipids in Health & Disease, 2016, v. 15, p. 1, doi. 10.1186/s12944-016-0282-8
- By:
- Publication type:
- Article
Lipid-Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long-Term Experience in a Large Group of Patients with Hypercholesterolemia.
- Published in:
- Clinical Cardiology, 2000, v. 23, n. 1, p. 39, doi. 10.1002/clc.4960230108
- By:
- Publication type:
- Article
Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial.
- Published in:
- 1996
- By:
- Publication type:
- journal article